HydRegen raises £2.6m from Clean Growth Fund to advance sustainable manufacturing technologies
Clean Growth Fund backed the biotechnology spin-out as it prepares to scale commercial operations.
Oxford-based biotechnology company developing bio-based catalysts for cleaner manufacturing in the pharmaceutical and chemical sectors.
Oxford-based biotechnology firm HydRegen has secured £2.6m in funding from Clean Growth Fund to support the commercial development of its bio-based manufacturing technologies.
The company will use the capital to scale its operations over the next 18 months, expand its team, and license its technology to chemical and pharmaceutical manufacturers worldwide. The investment aims to accelerate the deployment of greener alternatives to traditional metal catalysts.
Clean Growth Fund backed the round, bringing its clean-tech expertise to the company's commercial strategy as HydRegen works towards broader industry adoption and sustainability targets.
From the founder
"The HydRegen Team is hugely excited to embark on the next stage of our journey and to add CGF’s considerable expertise in clean tech to our commercial strategy. This funding will speed up the development of our greener and less wasteful bio-based manufacturing technologies, allowing us to help chemical companies to reduce their environmental impact and carbon footprint whilst also reducing their costs. HydRegen’s vision is to become part of the ‘advanced manufacturing toolbox’ across the global chemical manufacturing industry, enabling companies to meet their Net Zero goals."
Holly Reeve
CEO at HydRegen
Investor perspective
"The potential for HydRegen to revolutionise and decarbonise the chemical and pharmaceutical sectors is off-the-scale, and we are understandably excited about the company’s future."
Jonathan Tudor
Investment Partner, Clean Growth Fund
Use of funds
- 01Grow the team
- 02Continue product development
- 03Expand into international markets
